| Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis … JM Kocarnik, K Compton, FE Dean, W Fu, BL Gaw, JD Harvey, ... JAMA oncology 8 (3), 420-444, 2022 | 1484 | 2022 |
| Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021 SW Hanson, C Abbafati, JG Aerts, Z Al-Aly, C Ashbaugh, T Ballouz, ... JAMA 328 (16), 1604-1615, 2022 | 659 | 2022 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 648 | 2022 |
| Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study IM Osmanov, E Spiridonova, P Bobkova, A Gamirova, A Shikhaleva, ... European Respiratory Journal 59 (2), 2022 | 355 | 2022 |
| Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial SW Duffy, D Vulkan, H Cuckle, D Parmar, S Sheikh, RA Smith, A Evans, ... The Lancet Oncology 21 (9), 1165-1172, 2020 | 230 | 2020 |
| Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID‐19 D Munblit, P Bobkova, E Spiridonova, A Shikhaleva, A Gamirova, ... Clinical & Experimental Allergy 51 (9), 1107-1120, 2021 | 219 | 2021 |
| Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detection DP O'Brien, NS Sandanayake, C Jenkinson, A Gentry-Maharaj, ... Clinical Cancer Research 21 (3), 622-631, 2015 | 211 | 2015 |
| A time-resolved proteomic and prognostic map of COVID-19 V Demichev, P Tober-Lau, O Lemke, T Nazarenko, C Thibeault, ... Cell systems 12 (8), 780-794. e7, 2021 | 166 | 2021 |
| Excessive media consumption about COVID-19 is associated with increased state anxiety: outcomes of a large online survey in Russia NA Nekliudov, O Blyuss, KY Cheung, L Petrou, J Genuneit, N Sushentsev, ... Journal of medical Internet research 22 (9), e20955, 2020 | 147 | 2020 |
| Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples A Kazarian, O Blyuss, G Metodieva, A Gentry-Maharaj, A Ryan, ... British journal of cancer 116 (4), 501-508, 2017 | 129 | 2017 |
| Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019 B Armocida, L Monasta, S Sawyer, F Bustreo, G Segafredo, ... The Lancet Child & Adolescent Health 6 (6), 367-383, 2022 | 117 | 2022 |
| Improved early detection of ovarian cancer using longitudinal multimarker models HJ Whitwell, J Worthington, O Blyuss, A Gentry-Maharaj, A Ryan, R Gunu, ... British journal of cancer 122 (6), 847-856, 2020 | 94 | 2020 |
| A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021 SW Hanson, C Abbafati, JG Aerts, Z Al-Aly, C Ashbaugh, T Ballouz, ... MedRxiv, 2022 | 87 | 2022 |
| Stop COVID cohort: an observational study of 3480 patients admitted to the Sechenov university hospital network in Moscow City for suspected coronavirus disease 2019 (COVID-19 … D Munblit, NA Nekliudov, P Bugaeva, O Blyuss, M Kislova, E Listovskaya, ... Clinical Infectious Diseases 73 (1), 1-11, 2021 | 82 | 2021 |
| A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case–control study S Debernardi, H O’Brien, AS Algahmdi, N Malats, GD Stewart, ... PLoS Medicine 17 (12), e1003489, 2020 | 82 | 2020 |
| Discovery of non-invasive biomarkers for the diagnosis of endometriosis S Irungu, D Mavrelos, J Worthington, O Blyuss, E Saridogan, JF Timms Clinical proteomics 16 (1), 1-16, 2019 | 71 | 2019 |
| Comparison of longitudinal CA125 algorithms as a first-line screen for ovarian cancer in the general population O Blyuss, M Burnell, A Ryan, A Gentry-Maharaj, IP Mariño, J Kalsi, ... Clinical Cancer Research 24 (19), 4726-4733, 2018 | 64 | 2018 |
| Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population R Manchanda, O Blyuss, F Gaba, VS Gordeev, C Jacobs, M Burnell, ... Journal of medical genetics 55 (8), 538-545, 2018 | 64 | 2018 |
| Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients O Blyuss, A Zaikin, V Cherepanova, D Munblit, EM Kiseleva, ... British journal of cancer 122 (5), 692-696, 2020 | 61 | 2020 |
| Health-related quality of life in children and adults with primary immunodeficiencies: a systematic review and meta-analysis D Peshko, E Kulbachinskaya, I Korsunskiy, E Kondrikova, F Pulvirenti, ... The Journal of Allergy and Clinical Immunology: In Practice 7 (6), 1929-1957. e5, 2019 | 54 | 2019 |
alexey zaikinProfessor, University College London在 ucl.ac.uk 的电子邮件经过验证